Samsara Therapeutics
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- Undisclosed
Investors
- 2
About Samsara Therapeutics
Founded in 2018 and headquartered in Hamburg, Germany, Samsara Therapeutics specializes in therapeutics aimed at activating autophagy to treat neurodegenerative disorders.Samsara Therapeutics specializes in the development of therapeutics that leverage autophagy activation to address age-related neurodegenerative diseases. The company's core product offerings include a range of drug candidates designed to enhance autophagy processes, particularly focusing on lysosomal biogenesis and autophagosome formation. These therapies aim to slow the progression of conditions such as Alzheimer's and Parkinson's diseases, ultimately improving patient outcomes. The company is also targeting expansion into additional markets in North America and Europe, aiming for significant growth by the end of 2023.
Who invested in Samsara Therapeutics
2 investors across 3 rounds
See all investors in Samsara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Samsara Therapeutics
Who invested in Samsara Therapeutics?
Samsara Therapeutics has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Samsara Therapeutics raised?
Samsara Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Samsara Therapeutics last raise money?
Samsara Therapeutics's most recent round on record is a Series A, in Sep 2022.
What does Samsara Therapeutics do?
Founded in 2018 and headquartered in Hamburg, Germany, Samsara Therapeutics specializes in therapeutics aimed at activating autophagy to treat neurodegenerative disorders.
Where is Samsara Therapeutics headquartered?
Samsara Therapeutics is headquartered in Hamburg, Germany.
Which VCs invest in companies like Samsara Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Samsara Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Samsara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.